litlas
ログインアカウント作成

Bonnie S. Glisson

1984–2025 年に発表

105
論文数
24,100
被引用数
81
h 指数
103
i10 指数

被引用数

Bonnie S. Glisson の年別被引用数1985 年: 被引用 6 件1986 年: 被引用 5 件1987 年: 被引用 29 件1988 年: 被引用 17 件1989 年: 被引用 37 件1990 年: 被引用 26 件1991 年: 被引用 23 件1992 年: 被引用 15 件1993 年: 被引用 5 件1994 年: 被引用 13 件1995 年: 被引用 7 件1996 年: 被引用 10 件1997 年: 被引用 22 件1998 年: 被引用 19 件1999 年: 被引用 26 件2000 年: 被引用 31 件2001 年: 被引用 45 件2002 年: 被引用 56 件2003 年: 被引用 71 件2004 年: 被引用 93 件2005 年: 被引用 96 件2006 年: 被引用 100 件2007 年: 被引用 75 件2008 年: 被引用 87 件2009 年: 被引用 79 件2010 年: 被引用 88 件2011 年: 被引用 88 件2012 年: 被引用 87 件2013 年: 被引用 96 件2014 年: 被引用 106 件2015 年: 被引用 144 件2016 年: 被引用 146 件2017 年: 被引用 151 件2018 年: 被引用 184 件2019 年: 被引用 694 件2020 年: 被引用 851 件2021 年: 被引用 933 件2022 年: 被引用 813 件2023 年: 被引用 611 件2024 年: 被引用 933 件2025 年: 被引用 481 件2026 年: 被引用 6 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,831 件、この内訳の 30%中国: 引用元論文 1,344 件、この内訳の 14.2%イタリア: 引用元論文 490 件、この内訳の 5.2%イギリス: 引用元論文 432 件、この内訳の 4.6%日本: 引用元論文 420 件、この内訳の 4.4%ドイツ: 引用元論文 365 件、この内訳の 3.9%フランス: 引用元論文 358 件、この内訳の 3.8%カナダ: 引用元論文 292 件、この内訳の 3.1%スペイン: 引用元論文 279 件、この内訳の 3%オランダ: 引用元論文 278 件、この内訳の 2.9%オーストラリア: 引用元論文 211 件、この内訳の 2.2%韓国: 引用元論文 172 件、この内訳の 1.8%
0%30%その他 20.9%

機関

分野

  • Medicine74.5%
  • Biochemistry, Genetics and Molecular Biology16.5%
  • Immunology and Microbiology5.3%
  • Materials Science1%
  • Engineering0.8%
  • Health Professions0.5%
  • その他1.4%

トピック

  • Lung Cancer Treatments and Mutations7.4%
  • Lung Cancer Research Studies7.1%
  • Head and Neck Cancer Studies6.7%
  • Cancer Immunotherapy and Biomarkers5.2%
  • Cancer Genomics and Diagnostics2.9%
  • Cancer therapeutics and mechanisms2.5%
  • その他68.2%

共著者

全論文

検索で開く
  1. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

    著者: Carl M. Gay, C. Allison Stewart, Elizabeth M. Park, Lixia Diao, Sarah M. Groves, Simon Heeke, Barzin Y. Nabet, Junya Fujimoto, Luisa M. Solis, Wei Lü, Yuanxin Xi, Robert J. Cardnell, Qi Wang, Giulia Fabbri, Kasey R. Cargill, Natalie I. Vokes, Kavya Ramkumar, Bingnan Zhang, Carminia Maria Della Corte, Paul Robson, Stephen G. Swisher, Jack A. Roth, Bonnie S. Glisson, David S. Shames, Ignacio I. Wistuba, Jing Wang, Vito Quaranta, John D. Minna, John V. Heymach, Lauren A. Byers - Cancer Cell 2021 被引用: 932

  2. Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer

    著者: Triparna Sen, B. Leticia Rodriguez, Limo Chen, Carminia Maria Della Corte, Naoto Morikawa, Junya Fujimoto, Sandra Cristea, Thuyen Nguyen, Lixia Diao, Lerong Li, You-Hong Fan, Yongbin Yang, Jing Wang, Bonnie S. Glisson, Ignacio I. Wistuba, Julien Sage, John V. Heymach, Don L. Gibbons, Lauren A. Byers - Cancer Discovery 2019 被引用: 881

  3. Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

    著者: Tina Cascone, Cheuk Hong Leung, Annikka Weissferdt, Apar Pataer, Brett W. Carter, Myrna C. B. Godoy, Hope Feldman, William N. William, Yuanxin Xi, Sreyashi Basu, Jing Sun, Shalini S. Yadav, Frank Rojas Alvarez, Younghee Lee, Aditya K. Mishra, Lili Chen, Monika Pradhan, Haiping Guo, Ansam Sinjab, Nicolas Zhou, Marcelo V. Negrão, Xiuning Le, Carl M. Gay, Anne S. Tsao, Lauren A. Byers, Mehmet Altan, Bonnie S. Glisson, Frank V. Fossella, Yasir Y. Elamin, George Blumenschein, Jianjun Zhang, Ferdinandos Skoulidis, Jia Wu, Reza J. Mehran, David C. Rice, Garrett L. Walsh, Wayne L. Hofstetter, Ravi Rajaram, Mara B. Antonoff, Junya Fujimoto, Luisa M. Solis, Edwin R. Parra, Cara Haymaker, Ignacio I. Wistuba, Stephen G. Swisher, Ara A. Vaporciyan, Heather Lin, Jing Wang, Don L. Gibbons, J. Jack Lee, Nadim J. Ajami, Jennifer A. Wargo, James P. Allison, Padmanee Sharma, Humam Kadara, John V. Heymach, Boris Sepesi - Nature Medicine 2023 被引用: 206

  4. Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

    著者: Marcelo V. Negrão, Ferdinandos Skoulidis, Meagan Montesion, Katja Schulze, Ilze Bāra, Vincent K. Shen, Hao Xu, Sylvia Hu, Dawen Sui, Yasir Y. Elamin, Xiuning Le, Michael E. Goldberg, Karthikeyan Murugesan, Chang‐Jiun Wu, Jianhua Zhang, Jianhua Zhang, David S Barreto, Jacqulyne Robichaux, Alexandre Reuben, Tina Cascone, Carl M. Gay, K. G. Mitchell, Lingzhi Hong, Waree Rinsurongkawong, Jack A. Roth, Stephen G. Swisher, J. Jack Lee, Anne S. Tsao, Vassiliki A. Papadimitrakopoulou, Don L. Gibbons, Bonnie S. Glisson, Gaurav Singal, Vincent A. Miller, Brian M. Alexander, Garrett M. Frampton, Lee A. Albacker, David S. Shames, Jianjun Zhang, Jianjun Zhang, John V. Heymach - Journal for ImmunoTherapy of Cancer 2021 被引用: 292

  5. Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    著者: Mark G. Kris, Bruce E. Johnson, Lynne D. Berry, David J. Kwiatkowski, A. John Iafrate, Ignacio I. Wistuba, Marileila Varella‐Garcia, Wilbur A. Franklin, Samuel L. Aronson, Pei-Fang Su, Yu Shyr, D. Ross Camidge, Lecia V. Sequist, Bonnie S. Glisson, Fadlo R. Khuri, Edward B. Garon, William Pao, Charles M. Rudin, Joan H. Schiller, Eric B. Haura, Mark A. Socinski, Keisuke Shirai, Heidi Chen, Giuseppe Giaccone, Marc Ladanyi, Kelly Kugler, John D. Minna, Paul A. Bunn - JAMA 2014 被引用: 1,744

  6. Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer

    著者: C. Allison Stewart, Carl M. Gay, Yuanxin Xi, Santhosh Sivajothi, V. Sivakamasundari, Junya Fujimoto, Mohan Bolisetty, Patrice M. Hartsfield, Veerakumar Balasubramaniyan, Milind D. Chalishazar, César A. Moran, Neda Kalhor, John Stewart, Hai T. Tran, Stephen G. Swisher, Jack A. Roth, Jianjun Zhang, John de Groot, Bonnie S. Glisson, Trudy G. Oliver, John V. Heymach, Ignacio I. Wistuba, Paul Robson, Jing Wang, Lauren A. Byers - Nature Cancer 2020 被引用: 372

  7. Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study

    著者: Charles M. Rudin, M. Catherine Pietanza, Todd M. Bauer, Neal Ready, Daniel Morgensztern, Bonnie S. Glisson, Lauren A. Byers, Melissa L. Johnson, Howard A. Burris, Francisco Robert, Tae Hyung Han, Sheila Bheddah, Noah Theiss, Sky Watson, Deepan Mathur, Bharathi Vennapusa, Hany Zayed, Satwant Lally, Donald K. Strickland, Ramaswamy Govindan, Scott J. Dylla, Stanford L. Peng, David R. Spigel - The Lancet Oncology 2016 被引用: 553

  8. Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16–Related Cancer

    著者: Erminia Massarelli, William William, Faye M. Johnson, Merrill S. Kies, Renata Ferrarotto, Ming Guo, Lei Feng, J. Jack Lee, Hai T. Tran, Young Uk Kim, Cara Haymaker, Chantale Bernatchez, Michael A. Curran, Tomás Zecchini Barrese, Jaime Rodriguez Canales, Ignacio I. Wistuba, Lerong Li, Jing Wang, Sjoerd H. van der Burg, Cornelis J.M. Melief, Bonnie S. Glisson - JAMA Oncology 2018 被引用: 471

  9. Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study

    著者: Daniel Morgensztern, Benjamin Besse, Laurent Greillier, Rafael Santana-Dávila, Neal Ready, Christine L. Hann, Bonnie S. Glisson, Anna F. Farago, Afshin Dowlati, Charles M. Rudin, Sylvestre Le Moulec, Satwant Lally, Sreeni Yalamanchili, Jürgen Wolf, Ramaswamy Govindan, David P. Carbone - Clinical Cancer Research 2019 被引用: 322

  10. Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

    著者: Lauren A. Byers, Jing Wang, Monique B. Nilsson, Junya Fujimoto, Pierre Saintigny, John S. Yordy, Uma Giri, Michael Peyton, You Hong Fan, Lixia Diao, Fatemeh Masrorpour, Li Shen, Wenbin Liu, Boris Duchemann, Praveen K. Tumula, Vikas Bhardwaj, James Welsh, Stephanie Weber, Bonnie S. Glisson, Neda Kalhor, Ignacio I. Wistuba, Luc Girard, Scott M. Lippman, Gordon B. Mills, Kevin R. Coombes, John N. Weinstein, John D. Minna, John V. Heymach - Cancer Discovery 2012 被引用: 571

  11. Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR -Mutant NSCLC

    著者: Xiuning Le, Sonam Puri, Marcelo V. Negrão, Monique B. Nilsson, Jacqulyne Robichaux, Theresa A. Boyle, J. Kevin Hicks, Katherine L. Lovinger, Emily Roarty, Waree Rinsurongkawong, Ming Tang, Huiying Sun, Yasir Y. Elamin, Lara Lacerda, Jeff Lewis, Jack A. Roth, Stephen G. Swisher, J. Jack Lee, William N. William, Bonnie S. Glisson, Jianjun Zhang, Vassiliki A. Papadimitrakopoulou, Jhanelle E. Gray, John V. Heymach - Clinical Cancer Research 2018 被引用: 386

  12. Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer

    著者: Arlene A. Forastiere, Helmuth Goepfert, Moshe Maor, Thomas F. Pajak, Randal S. Weber, William H. Morrison, Bonnie S. Glisson, Andy Trotti, John A. Ridge, C. Chao, Glen Peters, Ding-Jen Lee, Andrea Leaf, John F. Ensley, Jay S. Cooper - New England Journal of Medicine 2003 被引用: 3,171

  13. Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer

    著者: Arlene A. Forastiere, Qiang Zhang, Randal S. Weber, Moshe Maor, Helmuth Goepfert, Thomas F. Pajak, William H. Morrison, Bonnie S. Glisson, Andy Trotti, John A. Ridge, Wade L. Thorstad, Henry Wagner, John F. Ensley, Jay S. Cooper - Journal of Clinical Oncology 2012 被引用: 1,278

  14. Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

    著者: Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, Michael Rubin, Ying Yuan, Diana Bell, Adel K. El‐Naggar, Jason M. Johnson, William H. Morrison, David I. Rosenthal, Bonnie S. Glisson, Faye M. Johnson, Charles Lu, Frank E. Mott, Bita Esmaeli, Eduardo M. Diaz, Paul W. Gidley, Ryan P. Goepfert, Carol M. Lewis, Randal S. Weber, Jennifer A. Wargo, Sreyashi Basu, Fei Duan, Shalini S. Yadav, Padmanee Sharma, James P. Allison, Jeffrey N. Myers, Neil D. Gross - Clinical Cancer Research 2021 被引用: 138

  15. Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8+ Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results

    著者: Renata Ferrarotto, Diana Bell, Maria Laura Rubin, Katherine A. Hutcheson, Jason M. Johnson, Ryan P. Goepfert, Jack Phan, Yasir Y. Elamin, Danice Torman, Carla L. Warneke, Amy C. Hessel, Adam S. Garden, Jeffrey N. Myers, Faye M. Johnson, J. Jack Lee, Andrew G. Sikora, Maura L. Gillison, Bonnie S. Glisson, Neil D. Gross - Clinical Cancer Research 2020 被引用: 127

  16. Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer

    著者: C. Allison Stewart, Pan Tong, Robert J. Cardnell, Triparna Sen, Lerong Li, Carl M. Gay, Fatemah Masrorpour, You Hong Fan, Rasha O. Bara, Ying Feng, Yuanbin Ru, Junya Fujimoto, Samrat T. Kundu, Leonard Post, Karen Yu, Yuqiao Shen, Bonnie S. Glisson, Ignacio I. Wistuba, John V. Heymach, Don L. Gibbons, Jing Wang, Lauren A. Byers - Oncotarget 2017 被引用: 227

  17. Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer

    著者: Jingying Nong, Yuhua Gong, Yanfang Guan, Xin Yi, Yuting Yi, Lianpeng Chang, Ling Yang, Jialin Lv, Zhirong Guo, Hongyan Jia, Yuxing Chu, Tao Liu, Ming Chen, Lauren A. Byers, Emily Roarty, Vincent K. Lam, Vassiliki A. Papadimitrakopoulou, Ignacio I. Wistuba, John V. Heymach, Bonnie S. Glisson, Zhongxing Liao, J. Jack Lee, P. Andrew Futreal, Shucai Zhang, Xuefeng Xia, Jianjun Zhang, Jinghui Wang - Nature Communications 2018 被引用: 219

  18. CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib

    著者: Triparna Sen, Pan Tong, C. Allison Stewart, Sandra Cristea, Aly Valliani, David S. Shames, Abena B. Redwood, You Hong Fan, Lerong Li, Bonnie S. Glisson, John D. Minna, Julien Sage, Don L. Gibbons, Helen Piwnica‐Worms, John V. Heymach, Jing Wang, Lauren A. Byers - Cancer Research 2017 被引用: 195

  19. Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC

    著者: Lingzhi Hong, Marcelo V. Negrão, Seyedeh Dibaj, Runzhe Chen, Alexandre Reuben, Jadi M. Bohac, Xiaoke Liu, Ferdinandos Skoulidis, Carl M. Gay, Tina Cascone, K. G. Mitchell, Hai T. Tran, Xiuning Le, Lauren A. Byers, Boris Sepesi, Mehmet Altan, Yasir Y. Elamin, Frank V. Fossella, Jonathan M. Kurie, Charles Lu, Frank E. Mott, Anne S. Tsao, Waree Rinsurongkawong, Jeff Lewis, Don L. Gibbons, Bonnie S. Glisson, George R. Blumenschein, Emily Roarty, P. Andrew Futreal, Ignacio I. Wistuba, Jack A. Roth, Stephen G. Swisher, Vassiliki A. Papadimitrakopoulou, John V. Heymach, J. Jack Lee, George R. Simon, Jianjun Zhang - Journal of Thoracic Oncology 2020 被引用: 192

  20. Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets

    著者: Renata Ferrarotto, Yoshitsugu Mitani, Daniel J. McGrail, Kaiyi Li, Tatiana V. Karpinets, Diana Bell, Steven J. Frank, Xingzhi Song, Michael E. Kupferman, Bin Liu, J. Jack Lee, Bonnie S. Glisson, Jianhua Zhang, Jon C. Aster, Shiaw‐Yih Lin, P. Andrew Futreal, John V. Heymach, Adel K. El‐Naggar - Clinical Cancer Research 2020 被引用: 140

  21. Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors

    著者: Renata Ferrarotto, Yoshitsugu Mitani, Lixia Diao, Irene Guijarro, Jing Wang, Patrick A. Zweidler‐McKay, Diana Bell, William N. William, Bonnie S. Glisson, Michael J. Wick, Ann M. Kapoun, Amita Patnaik, Gail Eckhardt, Pamela N. Münster, Leonardo Faoro, Jakob Dupont, J. Jack Lee, P. Andrew Futreal, Adel K. El‐Naggar, John V. Heymach - Journal of Clinical Oncology 2017 被引用: 245

  22. Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225

    著者: Nancy Lee, Jonathan Harris, Adam S. Garden, William L. Straube, Bonnie S. Glisson, Ping Xia, Walter Bosch, William H. Morrison, Jeanne M. Quivey, Wade L. Thorstad, Christopher U. Jones, K. Kian Ang - Journal of Clinical Oncology 2009 被引用: 709

  23. Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC

    著者: James W. Welsh, John V. Heymach, Chunxiao Guo, Hari Menon, Katherine Klein, Taylor R. Cushman, Vivek Verma, Kenneth R. Hess, Girish S. Shroff, Chad Tang, Ferdinandos Skoulidis, Melenda Jeter, Nathan Comeaux, Roshal R. Patel, Dawei Chen, Tugce Ozgen, Quynh-Nhu Nguyen, Joe Y. Chang, Mehmet Altan, Jianjun Zhang, Vassiliki A. Papadimitrakopoulou, George R. Simon, Lauren A. Byers, Bonnie S. Glisson - Journal of Thoracic Oncology 2020 被引用: 97

  24. ISA101 and nivolumab for HPV-16+ cancer: updated clinical efficacy and immune correlates of response

    著者: Luana Guimarães de Sousa, Kimal Rajapakshe, Jaime Rodriguez Canales, Renee L. Chin, Lei Feng, Qi Wang, Tomás Zecchini Barrese, Erminia Massarelli, William William, Faye M. Johnson, Renata Ferrarotto, Ignacio Wistuba, Cristian Coarfa, J. Jack Lee, Jing Wang, Cornelis J.M. Melief, Michael A. Curran, Bonnie S. Glisson - Journal for ImmunoTherapy of Cancer 2022 被引用: 92